Mandrik, Olena

Olena Mandrik

MSc Maastricht (the Netherlands), PhD Rotterdam (the Netherlands)

School of Medicine and Population Health

Research Fellow

o.mandrik@sheffield.ac.uk
+44 114 222 6392

Regent Court (ScHARR)

Full contact details

Olena Mandrik
School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
��«Ӱҵ
S1 4DA

Profile: I joined HEDS as a modeller in October 2018 after two-year post-doctoral fellowship in the International Agency for Research on Cancer of the World Health Organization. Prior to this I was employed by the Erasmus University Rotterdam, School of Health Policy and Management, were earlier (2015) I defended my PhD. My path to science was long, and I have a seven-year experience in pharmaceutical business organizations. Starting from Manager in Pharmacoeconomics and growing to the Head of the Market Access Department, I was employed by such global companies as Janssen-Cilag, Merck, and Sanofi. Within HEDS I specialise in public health-related modelling projects, focussing particularly upon modelling of cancer prevention and early detection.

Research interests

Cancer prevention and early detection
Calibration of cancer natural history disease models
Implementation research
Global research

Current projects

I currently work on a microsimulation model for colorectal cancer

Publications

Show: Featured publications All publications

Featured publications

This person does not have any publications available.

All publications

Journal articles

Rajgor A, Hurley R, Douglas CM, Paterson C, Moor J, Lester S, Sionis S, Davies K, O'Hara J, Inman G , Jones T et al (2024) . Clinical Otolaryngology.
Hill H, Roadevin C, Duffy S, Mandrik O & Brentnall A (2024) . JAMA Network Open, 7(9).
Mandrik O, Thomas C & Chilcott J (2024) Development of the Microsimulation Model in Cancers of Bladder and Kidney (MiMiC-BlaKy). HEDS Discussion Paper Series(24.03).
Catto JWF, North B, Goff M, Carter A, Sleeth M, Mandrik O, Chilcott J, Sasieni P & Cumberbatch MGK (2023) . BMJ Open, 13(9).
Mandrik O, Roitberg F, Lauby-Secretan B, Parak U, Ramadas K, Varenne B, Sankaranarayanan R & Carvalho AL (2023) . Journal of Cancer Policy, 35.
Bouvard V, Nethan ST, Singh D, Warnakulasuriya S, Mehrotra R, Chaturvedi AK, Chen TH-H, Ayo-Yusuf OA, Gupta PC, Kerr AR , Tilakaratne WM et al (2022) . New England Journal of Medicine.
Parak U, Lopes Carvalho A, Roitberg F & Mandrik O (2022) . Preventive Medicine Reports, 30, 101987-101987.
Lourenção M, Simões Correa Galendi J, Galvão HDCR, Antoniazzi AP, Grasel RS, Carvalho AL, Mauad EC, Oliveira JHCD, Reis RM, Mandrik O & Palmero EI (2022) . Frontiers in Oncology, 12.
Thomas C, Mandrik O & Whyte S (2022) . Preventive Medicine.
Mandrik O, Fotheringham J, Ren S, Tice JA, Chapman RH, Stevenson MD, Pearson SD, Herron-Smith S, Agboola F & Thokala P (2022) . Clinical Journal of the American Society of Nephrology, 17(3), 385-394.
Tice JA, Mandrik O, Thokala P, Fotheringham J & Pearson SD (2021) . Journal of Managed Care & Specialty Pharmacy, 27(10), 1495-1499.
Daubner-Bendes R, Kovács S, Niewada M, Huic M, Drummond M, Ciani O, Blankart CR, Mandrik O & Kaló Z (2021) . Frontiers in Public Health.
Escriva-Boulley G, Mandrik O, Préau M, Herrero R & Villain P (2020) . Preventive Medicine.
Isah AUJ, Ekwunife OI, Ejie IL & Mandrik O (2020) . PLoS ONE, 15(8).
Mandrik O, Tolma E, Zielonke N, Meheus F, Ordóñez-Reyes C, Severens H & Murillo R (2020) . Journal of Medical Screening.
Mandrik O, Yaumenenka A, Herrero R & Jonker M (2019) . PLoS ONE, 1.
Mandrik O, Ekwunife O, Meheus F, Severens JL, Lhachimi S, Uyl-de Groot CA & Murillo R (2019) . Cancer Medicine.
Mandrik O, Zielonke N, Meheus F, Severens H, Guha N, Herrero R & Murillo R (2019) . International Journal of Cancer, 145(4), 994-1006.
Lin L, Severens JL & Mandrik O (2019) . PLoS ONE, 14(7).
Mandrik O, Ekwunife OI, Zielonke N, Meheus F, Severens JL, Lhachimi SK & Murillo R (2017) . Systematic Reviews, 6(1).
Mandrik O, Knies S, Golubovska О, Duda O, Dudar L, Fedorchenko S, Zaliska О & Severens JLH (2015) . Open Medicine, 10(1).
Mandrik O, Knies S, Kalo Z & Severens JL (2015) . International Journal of Technology Assessment in Health Care, 31(6), 434-441.
Mandrik O, Knies S, Kaló Z & Severens JL (2014) . Value in Health, 17(7), A443-A444.
Mandrik O, Corro Ramos I, Zalis’ka O, Gaisenko A & Severens JL (2013) . Value in Health Regional Issues, 2(2), 205-209.
Zalis'ka O & Mandrik O (2010) . Value in Health, 13(7), A400-A400.
Mandrik O, Thomas C, Akpan E, Catto JWF & Chilcott J () . PharmacoEconomics.
Villain P, Downham L, Le Bonniec A, Bauquier C, Mandrik O, Nadarzynski T, Donelle L, Murillo R, Tolma EL, Johnson S , Soler-Michel P et al () . Journal of Medical Internet Research.
Chanakira EZ, Thomas CV, Balen J & Mandrik O () . Systematic Reviews, 13(1).
Mandrik O, Hahn AI, Catto JWF, Zauber AG, Cumberbatch M & Chilcott J () . PharmacoEconomics.
Catto JWF, Mandrik O, Quayle LA, Hussain SA, McGrath J, Cresswell J, Birtle AJ, Jones RJ, Mariappan P, Makaroff LE , Knight A et al () . BJU International.
Mandrik O, Chilcott J & Thomas C () Modelling the impact of the coronavirus pandemic on bowel cancer screening outcomes in England: a decision analysis to prepare for future screening disruption. Preventive Medicine.
Thomas C, Mandrik O, Whyte S, Saunders C, Griffin S & Usher-Smith J () Should colorectal cancer screening start at different ages for men and women? Cost-effectiveness analysis for a resource constrained service. Cancer Reports.
Mandrik O, Corro Ramos I, Knies S, Al M & Severens JH () . Cancer Management and Research, 279-279.
Mandrik O, Knies S & Severens JH () . ClinicoEconomics and Outcomes Research, 347-347.
Mandrik O, Mankovsky B, Doroshenko O, Pan'kiv V, Kravchun N, Vlasenko M, Hulchiy M, Baljuk M, Komisarenko Y, Martsynik E , Sokolova L et al () . Journal of Multidisciplinary Healthcare, 249-249.
Mandrik O, Severens JL, Bardach A, Ghabri S, Hamel C, Mathes T, Vale L, Wisløff T & Goldhaber-Fiebert JD () Critical Appraisal of Systematic Reviews with Costs and Cost-effectiveness Outcomes: an ISPOR Good Practices Task Force Report. Value in Health.
Thomas C, Mandrik O, Saunders CL, Thompson D, Whyte S, Griffin S & Usher-Smith JA () . Cancer Prevention Research, canprevres.0620.2020-canprevres.0620.2020.
Mandrik O, Thomas C, Whyte S & Chilcott J () CALIBRATING NATURAL HISTORY OF CANCER MODELS IN THE PRESENCE OF DATA INCOMPATIBILITY; PROBLEMS AND SOLUTIONS. PharmacoEconomics.

Conference proceedings papers

Villain P, Downham L, Le Bonniec A, Bauquier C, Mandrik O, Nadarzynski T, Donelle L, Johnson S, Murillo R, Soler-Michel P , Tolma EL et al (2024) Effect of online interactive decision tools on breast cancer screening decisions: A systematic review and meta-analysis. INTERNATIONAL JOURNAL OF CANCER, Vol. 155 (pp 24-24)
Mandrik O, Zalis'ka O & Severens J (2012) . Value in Health, Vol. 15(7) (pp A428-A428)
Mandrik O, Zalis'ka O & Severens JL (2012) . Value in Health, Vol. 15(4) (pp A221-A221)
Pariy V, Stepanenko A, Mandrik O & Zalis'ka O (2012) . Value in Health, Vol. 15(4) (pp A32-A32)
Mandrik O, Severens JL, Zalis'ka O, Doroshenko O, Maynych Y & Tolubaiev V (2012) . Value in Health, Vol. 15(4) (pp A28-A28)
Mandrik O, Zalis'ka O & Severens JL (2011) . Value in Health, Vol. 14(7) (pp A444-A444)
Mandrik O & Zalis'ka O (2011) . Value in Health, Vol. 14(3) (pp A163-A163)

Datasets

Mandrik O, Yaumenenka A, Herrero R & Jonker MF .

Preprints

Villain P, Downham L, Le Bonniec A, Bauquier C, Mandrik O, Nadarzynski T, Donelle L, Murillo R, Tolma EL, Johnson S , Soler-Michel P et al (2024) , JMIR Publications Inc..
Mandrik O, Thomas C, Strong M & Whyte S (2021) Calibration and Validation of the Microsimulation Model in Cancer of the Bowel (MiMiC-Bowel), an Individual Patient Simulation Model for Investigation of the Cost-effectiveness of Personalised Screening and Surveillance Strategies..